Table 4 Co-morbidities of patients with DFU in selected referral hospitals in Uganda, November 2021 to January 2022 (n = 117)
Variables | Early (G1&G2) n(%) | Late (G3, G4, &G5)n(%) | Total n (%) | p-value |
|---|---|---|---|---|
Neuropathy | Â | Â | Â | 0.013 |
Absent | 16 (34.0) | 8 (11.4) | 24 (20.5) | Â |
Mild | 3 (6.4) | 8 (11.4) | 11 (9.4) | Â |
Moderate | 18 (38.3) | 26 (37.1) | 44 (37.6) | Â |
Severe | 10 (21.3) | 28 (40.0) | 38 (32.5) | Â |
Peripheral Vascular Disease | Â | Â | Â | 0.103 |
No disease | 35 (74.5) | 41 (58.6) | 76 (65.0) | Â |
Claudication | 10 (21.3) | 24 (27.1) | 34 (29.1) | Â |
Gangrene | 0 (0.0) | 7 (10.0) | 7 (6.0) | Â |
DVT | 2 (4.3) | 3 (4.3) | 5 (4.3) | Â |
Hba1C, mean (SD) | 8.3 (2.6) | 8.8 (2.6) | 8.6 (2.6) | 0.158 |
Hba1C levels | Â | Â | Â | Â |
Less than 6.5% | 14 (29.8) | 13 (18.6) | 27 (23.1) | Â |
6.5% and above | 33 (70.2) | 57 (81.4) | 90 (76.9) | 0.158 |
BP class | Â | Â | Â | Â |
Normal | 19 (40.4) | 28 (40.0) | 47 (40.2) | Â |
Hypertension | 28 (59.6) | 41 (58.6) | 69 (59.0) | Â |
Hypotension | 0 (0.0) | 1 (1.4) | 1 (0.9) | Â |
BMI, mean (SD) | 25.9 (6.7) | 25.0 (5.2) | 25.3 (5.9) | 0.393 |
BMI group | Â | Â | Â | 0.614 |
Underweight < 18.5 | 3 (6.4) | 5 (7.1) | 8 (6.8) |  |
Normal 18.5–24.9 | 21 (44.7) | 35 (50.0) | 56 (47.9) |  |
Pre-obesity 25.0–29.9 | 16 (34.0) | 22 (31.4) | 38 (32.5) |  |
Obesity Class I 30.0–34.9 | 3 (6.4) | 6 (8.6) | 9 (7.7) |  |
Obesity Class II 35.0–39.9 | 2 (4.3) | 0 (0.0) | 2 (1.7) |  |
Obesity Class III 40 and above | 2 (4.3) | 2 (2.9) | 4 (3.4) | Â |
ABI group | Â | Â | Â | 0.192 |
Normal (1.0 to 1.4) | 9(0.1) | 19(0.2) | 28(0.2) | Â |
Acceptable (0.9 to less 1.0) | 4(0.03) | 3(0.03) | 7(0.1) | Â |
Some Arterial Disease (0.8 to less 0.9) | 1(0.01) | 0(0.0) | 1(0.01) | Â |
Moderate (0.5 to 0.7) | 0(0.0) | 2(0.02) | 2(0.02) | Â |
Severe (Less than 0.5) | 0(0.0) | 2(0.02) | 2(0.02) | Â |
Not assessed | 31(0.3) | 46(0.4) | 77(0.7) | Â |